Jillian M. Baker

ORCID: 0000-0001-5935-8339
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood groups and transfusion
  • Hemoglobinopathies and Related Disorders
  • CAR-T cell therapy research
  • Neonatal Health and Biochemistry
  • Platelet Disorders and Treatments
  • Erythrocyte Function and Pathophysiology
  • Childhood Cancer Survivors' Quality of Life
  • Adolescent and Pediatric Healthcare
  • Immune Cell Function and Interaction
  • Blood disorders and treatments
  • Blood properties and coagulation
  • Vaccine Coverage and Hesitancy
  • Iron Metabolism and Disorders
  • Lymphoma Diagnosis and Treatment
  • Respiratory viral infections research
  • Polyomavirus and related diseases
  • Healthcare Systems and Technology
  • Nanowire Synthesis and Applications
  • Methemoglobinemia and Tumor Lysis Syndrome
  • Abdominal Trauma and Injuries
  • Congenital Diaphragmatic Hernia Studies
  • Biosimilars and Bioanalytical Methods
  • Misinformation and Its Impacts
  • Acute Lymphoblastic Leukemia research
  • Integrated Circuits and Semiconductor Failure Analysis

Children's Hospital of Philadelphia
2024-2025

St. Michael's Hospital
2013-2024

Hospital for Sick Children
2010-2024

SickKids Foundation
2006-2024

University of Maryland, Baltimore
2021-2024

University of Toronto
2006-2022

Unity Health Toronto
2022

St Michael’s Hospital
2020-2021

Canada Research Chairs
2020

Palmetto Hematology Oncology
2013

Summary Hereditary spherocytosis (HS) is a common inherited haemolytic anaemia attributed to disturbances in five different red cell membrane proteins. We performed retrospective study of 166 children with HS and describe the clinical phenotype according genotype. In 160/166 (97%) disease‐causing mutation was identified. Pathogenic variants ANK1 , SPTB SLC4A1 SPTA1 were found 49%, 33%, 13% 5% patients. Children ‐HS had mildest phenotype, showing highest haemoglobin ( P < 0·001), lowest...

10.1111/bjh.16750 article EN British Journal of Haematology 2020-05-20

T cells expressing chimeric antigen receptors (CARs) have shown remarkable therapeutic activity against different types of cancer. However, the wider use CAR has been hindered by potential for life-threatening toxicities due to on-target off-tumor killing low amounts target antigen. CD229, a signaling lymphocyte-activation molecule (SLAM) family member, previously identified as cell–mediated treatment multiple myeloma (MM) its high expression on surfaces MM cells. CD229 effective clearance...

10.1126/scitranslmed.add7900 article EN Science Translational Medicine 2023-07-19

Abstract Background Aggressive B cell lymphoma with secondary central nervous system (CNS) involvement (SCNSL) carries a dismal prognosis. Chimeric antigen receptor (CAR) T cells (CAR-T) targeting CD19 have revolutionized the treatment for lymphomas; however, only single cases CNS manifestations successfully treated CAR-T been reported. Methods We prospectively enrolled 4 patients SCNSL into our study to assess clinical responses and monitor immunity. Results Two of four SNCSL responded...

10.1007/s00262-023-03619-9 article EN cc-by Cancer Immunology Immunotherapy 2024-02-13

Haemolytic disease of the newborn (HDN) can be associated with significant morbidity. Prompt treatment intensive phototherapy (PT) and exchange transfusions (ETs) dramatically improve outcomes. ET is invasive risks. Intravenous immunoglobulin (IVIG) may an alternative therapy to prevent use ET. An international panel experts was convened develop evidence-based recommendations regarding effectiveness safety IVIG reduce need for ETs, neurocognitive outcomes, bilirubin level, frequency red...

10.1111/bjh.18170 article EN cc-by-nc-nd British Journal of Haematology 2022-04-12

Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication following kidney transplantation, and there critical unmet need for PTLD treatments associated with more pronounced durable responses. To date, reports on the use of CD19-targeted chimeric antigen receptor (CAR) T (CAR-T) cells in patients after solid organ transplant (SOT) have been anecdotal, clinical presentations outcomes heterogenous, longitudinal analysis CAR-T cell expansion persistence has not...

10.1080/21645515.2023.2216116 article EN cc-by-nc-nd Human Vaccines & Immunotherapeutics 2023-06-06

ABSTRACT Chimeric antigen receptor (CAR) T cells are an effective treatment for some blood cancers. However, the lack of tumor-specific surface antigens limits their wider use. We identified a set that limited in expression to cancer and central nervous system (CNS). developed CAR against one these antigens, LINGO1, which is widely expressed Ewing sarcoma (ES). To prevent CNS targeting, we engineered LINGO1 lacking integrin ⍺ 4 (A4 ko ), adhesion molecule essential migration across...

10.1101/2024.02.08.579002 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-02-11

Human metapneumovirus (hMPV) has recently emerged as an important cause of lower respiratory tract infections in hospitalized children, causing severe pneumonia and failure among immunocompromised patients. We retrospectively examined 30 children diagnosed with cancer whose nasopharyngeal swabs were positive for hMPV by direct fluorescent testing over a 5-year period. In 16/30 (53.3%) infection was confined to the upper tract, whereas occurred 46.7%. The median duration illness 6.5 days...

10.1097/mph.0b013e31828ac89c article EN Journal of Pediatric Hematology/Oncology 2013-04-12
Julia R. Sharp Jonathon L. Maguire Sarah Carsley Kawsari Abdullah Yang Chen and 95 more Eliana M. Perrin Patricia C. Parkin Catherine S. Birken Catherine S. Birken Jonathon L. Maguire Eddy Lau Andreas Laupacis Patricia C. Parkin Michael Salter Péter Szatmári Shannon Weir Kawsari Abdullah Mary Aglipay Yamna Ali Laura N. Anderson Imaan Bayoumi Catherine S. Birken Cornelia M. Borkhoff Sarah Carsley Shi‐Yi Chen Yang Chen David Dai Denise Darmawikarta Cindy‐Lee Dennis Karen Eny Stephanie C. Erdle Kayla Furlong Kanthi Kavikondala Christine Koroshegyi Christine Kowal Grace Jieun Lee Jonathon L. Maguire Dalah Mason Jessica Omand Patricia C. Parkin Navindra Persaud Lesley Plumptre Meta van den Heuvel Shelley Vanderhout Peter Wong Weeda Zabih M. B. Abdurrahman Barbara Anderson Laura N. Anderson Gordon Arbess Jillian M. Baker Tony Barozzino Sylvie Bergeron Dimple Bhagat Nicholas Blanchette Gary Bloch Joey Bonifacio Ashna Bowry Anne Brown Jennifer Bugera Caroline Calpin Douglas Campbell Sohail Cheema Elaine Cheng Brian Chisamore Evelyn Constantin Erin Culbert Karoon Danayan Paul Das Mary Beth Derocher Kieu Anh Michael W. Dorey Kathleen Doukas Anne E. Egger Allison Farber Amy L. Freedman Sloane Freeman Keewai Fung Sharon Gazeley Donna Goldenberg Charlie Guiang Dan Ha Hafiz Shuja Curtis Handford Laura Hanson Leah Harrington Hailey Hatch Teresa Hughes Sheila Jacobson Lukasz Jagiello Gwen Jansz Paul Kadar Tara Kiran Lauren Kitney Holly Knowles Bruce Kwok Sheila Lakhoo Margarita Lam-Antoniades Eddy Lau Fok‐Han Leung

10.1016/j.acap.2017.08.006 article EN Academic Pediatrics 2017-08-24

Asplenia and hyposplenia (a/hyposplenia) are associated with increased morbidity mortality from complications including infection. The recommended measures to reduce the risks infection include patient education, vaccination early initiation of antibiotic therapy for fever. Despite these recommendations, there is poor adherence best practice management patients asplenia or (PWA/H). We present development methodology pilot data a quality improvement project that explored whether programme...

10.1136/bmjoq-2019-000770 article EN cc-by-nc BMJ Open Quality 2020-08-01

Abstract Several factors unique to Fanconi anemia (FA) limit the success of allogeneic hematopoietic stem cell transplantation (HSCT) in this population. In report, we describe a multi‐center pilot study five consecutive FA patients with high‐risk features for transplant prepared fludarabine, without radiation. Four engrafted quickly, experienced minimal toxicity and are well at 43–65 months post‐transplant. One patient had C‐mismatched unrelated donor unsustained engraftment. This...

10.1002/pbc.21921 article EN Pediatric Blood & Cancer 2009-01-20

Abstract Cystic partially differentiated nephroblastoma (CPDN) has low malignant potential. We report a 1‐year‐old with stage III CPDN of the right kidney that recurred following radical nephrectomy and chemotherapy. There was evidence tumor spillage pre‐operatively intra‐operatively. During chemotherapy disease in omentum peritoneum. Pathology recurrent resected cysts revealed more biphasic without blastemal elements. It appears our patient led to dissemination disease. Chemotherapy failed...

10.1002/pbc.20930 article EN Pediatric Blood & Cancer 2006-06-19
Coming Soon ...